000 01284 a2200361 4500
005 20250516104951.0
264 0 _c20130204
008 201302s 0 0 eng d
022 _a1096-9098
024 7 _a10.1002/jso.23230
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aO'Reilly, Eileen M
245 0 0 _aAdjuvant therapy for pancreas adenocarcinoma.
_h[electronic resource]
260 _bJournal of surgical oncology
_cJan 2013
300 _a78-85 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCancer Vaccines
650 0 4 _aChemoradiotherapy
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aCombined Modality Therapy
650 0 4 _aDeoxycytidine
_xadministration & dosage
650 0 4 _aErlotinib Hydrochloride
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aPancreatic Neoplasms
_xdrug therapy
650 0 4 _aQuinazolines
_xadministration & dosage
650 0 4 _aTreatment Outcome
650 0 4 _aGemcitabine
773 0 _tJournal of surgical oncology
_gvol. 107
_gno. 1
_gp. 78-85
856 4 0 _uhttps://doi.org/10.1002/jso.23230
_zAvailable from publisher's website
999 _c22019391
_d22019391